drugset / Trial / NCT01580644

Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers

NCT01580644 ↗

Phase 1 Completed 12 enrolled Lakefront Biotherapeutics NV
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the amount of GLPG0187 present in the blood (pharmacokinetics) after a single oral dose of the prodrug of GLPG0187 given to healthy subjects. Two formulations of the GLPG0187 prodrug will be compared, as well as the effect of food and dose proportionality of the best formulation. Furthermore, during the course of the study, safety and tolerability will be characterized.

Timeline

Start
2012-01
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG0187 prodrug Unknown — Oral

Indications

No indication recorded.